Breaking News Instant updates and real-time market news.

MDCO

The Medicines Co.

$35.38

-1.01 (-2.78%)

17:30
06/24/19
06/24
17:30
06/24/19
17:30

The Medicines Co. files to sell $150M of common stock

Goldman Sachs & Co. and J.P. Morgan are acting as the joint book-running managers and underwriters for the offering.

MDCO The Medicines Co.
$35.38

-1.01 (-2.78%)

04/26/19
04/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cleveland-Cliffs (CLF) upgraded to Outperform from Neutral at Credit Suisse with analyst Curt Woodworth saying he sees potential value near $16-$18 once the HBI plant is fully ramped, even with low hot-rolled coil prices at that point in time. 2. Argo Group (ARGO) upgraded to Outperform from Market Perform at William Blair with analyst Adam Klauber saying Argo is beginning to emerge as a long-term midcap growth insurer, Klauber tells investors in a research note. 3. Illinois Tool Works (ITW) upgraded to Neutral from Underweight at JPMorgan with analyst Ann Duignan saying following the company's "solid" Q1 results, downside risk to 2019 earnings estimates "appears limited," with the worst of auto builds and European weakness "likely behind us." 4. The Medicines Co. (MDCO) upgraded to Buy from Neutral at Goldman Sachs while Esperion (ESPR) upgraded to Neutral from Sell. 5. Shutterfly (SFLY) upgraded to Outperform from Market Perform at Raymond James with analyst Aaron Kessler citing stable Consumer segment growth trends and his expectation for improved consumer growth throughout 2019, as well as "very achievable" 2021 EBITDA guidance of $400M-$450M with modest organic growth assumptions and modest Lifetouch synergies baked in. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/02/19
SBSH
05/02/19
NO CHANGE
Target $23
SBSH
Buy
Amarin selloff creates attractive entry point, says Citi
Citi analyst Joel Beatty believes the selloff yesterday in shares of Amarin (AMRN) brings an attractive entry point. He raised his price target for the stock to $23 from $20 and keeps a Buy rating on the name. The analyst sees five potential upside catalysts this year, including a likely supportive ICER cost-effectiveness review and potential priority review from the FDA. Further, while an acquisition of Amarin is possible, the company acquiring The Medicines Co. (MDCO) or Esperion (ESPR) "could also be a viable path," says Beatty.
05/20/19
NOMU
05/20/19
NO CHANGE
Target $62
NOMU
Reduce
Alnylam partner presented limited safety data, says Nomura Instinet
Alnylam Pharmaceuticals' (ALNY) partner, the Medicines Company (MDCO), presented on Saturday data from the ORION-3 trial of inclisiran, Nomura Instinet analyst Christopher Marai tells investors in a research note. The update did not suggest any surprise safety signals, as expected, but only limited safety data, according to Marai. He believes inclisiran's opportunity is a "show-me story" and more likely to become priced in post-approval after material sales. The analyst reiterates a Reduce rating on Alnylam shares with a $62 price target.
05/20/19
BARD
05/20/19
NO CHANGE
Target $110
BARD
Outperform
The Medicines Co. price target raised to $110 from $80 at Baird
Baird analyst Madhu Kumar reiterated an Overweight rating on The Medicines Co and raised his price target to $110 from $80. On Saturday, the company announced Phase 2 open-label extension ORION-3 data for PCSK9 RNAi drug inclisiran for hypercholesterolemia at the National Lipid Association meeting, Kumar tells investors in a research note, adding that these results have increased his conviction in inclisiran "ascending the Iron Throne" of PCSK9 drugs in ORION-9/10/11, for which top-line data are guided for in the third quarter. Phase 2 OLE results, he says, have effectively quashed bear safety concerns for inclisiran.

TODAY'S FREE FLY STORIES

INTU

Intuit

$276.05

-0.29 (-0.10%)

07:15
08/23/19
08/23
07:15
08/23/19
07:15
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MCD

McDonald's

$219.39

-1.29 (-0.58%)

, QSR

Restaurant Brands

$75.43

0.21 (0.28%)

07:15
08/23/19
08/23
07:15
08/23/19
07:15
Recommendations
McDonald's, Restaurant Brands, Carrols Restaurant analyst commentary  »

McDonald's…

MCD

McDonald's

$219.39

-1.29 (-0.58%)

QSR

Restaurant Brands

$75.43

0.21 (0.28%)

TAST

Carrols Restaurant

$7.07

-0.2 (-2.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 05

    Sep

  • 23

    Sep

  • 13

    Nov

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:14
08/23/19
08/23
07:14
08/23/19
07:14
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary  »

VMware price target…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

ARMK

Aramark

$39.93

0.22 (0.55%)

07:10
08/23/19
08/23
07:10
08/23/19
07:10
Initiation
Aramark initiated  »

Aramark initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRGB

Red Robin

$32.96

-0.64 (-1.90%)

07:10
08/23/19
08/23
07:10
08/23/19
07:10
Earnings
Red Robin cuts FY19 adj. EPS view to 95c-$1.50 from $1.14-$1.77 »

Consensus $1.14. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

CDNA

CareDx

$23.56

-0.16 (-0.67%)

07:07
08/23/19
08/23
07:07
08/23/19
07:07
Recommendations
CareDx analyst commentary  »

CareDx draft LCD should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

RRGB

Red Robin

$32.96

-0.64 (-1.90%)

07:07
08/23/19
08/23
07:07
08/23/19
07:07
Earnings
Red Robin reports Q2 adj. EPS $1.03, consensus 31c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

07:05
08/23/19
08/23
07:05
08/23/19
07:05
General news
FX Action: »

FX Action: The dollar has…

VMW

VMware

$148.15

0.11 (0.07%)

07:03
08/23/19
08/23
07:03
08/23/19
07:03
Recommendations
VMware analyst commentary  »

VMware price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 10

    Oct

FL

Foot Locker

$42.00

2.24 (5.63%)

07:02
08/23/19
08/23
07:02
08/23/19
07:02
Hot Stocks
Breaking Hot Stocks news story on Foot Locker »

Foot Locker down 9% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

ZIOP

Ziopharm

$5.61

0.46 (8.93%)

07:01
08/23/19
08/23
07:01
08/23/19
07:01
Hot Stocks
Ziopharm reports inducement grant under Nasdaq listing rule »

Ziopharm Oncology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

CRM

Salesforce

$148.26

0.86 (0.58%)

07:00
08/23/19
08/23
07:00
08/23/19
07:00
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

INTU

Intuit

$276.05

-0.29 (-0.10%)

06:57
08/23/19
08/23
06:57
08/23/19
06:57
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

RBNC

Reliant Bancorp

$22.46

-0.16 (-0.71%)

06:56
08/23/19
08/23
06:56
08/23/19
06:56
Initiation
Reliant Bancorp initiated  »

Reliant Bancorp initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CLH

Clean Harbors

$75.14

-0.25 (-0.33%)

06:53
08/23/19
08/23
06:53
08/23/19
06:53
Initiation
Clean Harbors initiated  »

Clean Harbors resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROST

Ross Stores

$107.31

1.63 (1.54%)

06:53
08/23/19
08/23
06:53
08/23/19
06:53
Recommendations
Ross Stores analyst commentary  »

Ross Stores price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEB

Hemispherx

$1.89

-0.02 (-1.05%)

06:52
08/23/19
08/23
06:52
08/23/19
06:52
Hot Stocks
Hemispherx changes name to AIM ImmunoTech, effective September 3 »

Hemispherx Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKE

The Buckle

$18.61

0.695 (3.88%)

06:50
08/23/19
08/23
06:50
08/23/19
06:50
Earnings
The Buckle reports Q2 EPS 34c, consensus 30c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

GPS

Gap

$17.75

0.79 (4.66%)

06:50
08/23/19
08/23
06:50
08/23/19
06:50
Recommendations
Gap analyst commentary  »

Gap price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

LNDC

Landec

$10.99

-0.07 (-0.63%)

06:50
08/23/19
08/23
06:50
08/23/19
06:50
Initiation
Landec initiated  »

Landec initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELL

Tellurian

$9.19

0.9 (10.86%)

06:49
08/23/19
08/23
06:49
08/23/19
06:49
Downgrade
Tellurian rating change  »

Tellurian downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.43

-0.41 (-0.20%)

, ALXN

Alexion

$123.51

8.64 (7.52%)

06:48
08/23/19
08/23
06:48
08/23/19
06:48
Recommendations
Amgen, Alexion analyst commentary  »

Amgen deal for Alexion…

AMGN

Amgen

$203.43

-0.41 (-0.20%)

ALXN

Alexion

$123.51

8.64 (7.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

  • 02

    Oct

  • 19

    Oct

FL

Foot Locker

$42.00

2.24 (5.63%)

06:47
08/23/19
08/23
06:47
08/23/19
06:47
Earnings
Foot Locker reports Q2 EPS ex-items 66c, consensus 67c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 19

    Sep

  • 25

    Sep

VWAGY

Volkswagen

$0.00

(0.00%)

06:47
08/23/19
08/23
06:47
08/23/19
06:47
Periodicals
Volkswagen looks for investment in China auto suppliers, Bloomberg says »

Volkswagen is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$18.91

-0.04 (-0.21%)

06:46
08/23/19
08/23
06:46
08/23/19
06:46
Recommendations
HP Inc. analyst commentary  »

HP Inc. price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.